Table 2 Characteristics of the eyes within the retinal conditions group
AMD | Diabetic retinopathy | Refractory chronic CME | Vein occlusion | High myopia | All eyes | |
|---|---|---|---|---|---|---|
N, eyes | 14 (30.4%) | 10 (21.7%) | 10 (21.7%) | 8 (17.4%) | 4 (8.7%) | 46 (100.0%) |
Clinical data | ||||||
Visual acuity, LogMAR | 0.31 ± 0.22 | 0.47 ± 0.66 | 0.74 ± 0.69 | 0.30 ± 0.13 | 0.27 ± 0.20 | 0.43 ± 0.48 |
Phakic lens status | 0 (0%) | 2 (20.0%) | 1 (10.0%) | 0 (0%) | 0 (0%) | 3 (6.5%) |
Glaucoma | 3 (21.4%) | 8 (80.0%) | 4 (40.0%) | 5 (62.5%) | 1 (25.0%) | 21 (45.7%) |
History of macular edema | 8 (57.1%) | 10 (100.0%) | 10 (100.0%) | 8 (100.0%) | 0 (0%) | 36 (78.3%) |
Intravitreal injections | ||||||
Anti-VEGF | 7 (87.5%) | 9 (90.0%) | 5 (50.0%) | 6 (75.0%) | 0 (0%) | 27 (58.7%) |
Steroids | 0 (0%) | 2 (20.0%) | 5 (50.0%) | 2 (25.0%) | 0 (0%) | 9 (16.1%) |
Laser treatment | ||||||
PRP | 0 (0%) | 9 (90.0%) | 0 (0%) | 6 (75.0%) | 0 (0%) | 15 (32.6%) |
FML | 0 (0%) | 3 (33.3%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (6.5%) |
Retinal tear | 0 (0%) | 1 (10.0%) | 0 (0%) | 0 (0%) | 2 (50.0%) | 3 (6.5%) |
Retinal detachment | 0 (0%) | 0 (0.0%) | 5 (50.0%) | 0 (0%) | 1 (25.0%) | 6 (13.0%) |
SD-OCT features | ||||||
Macular PVD† | 10/12 (83.3%) | 2/5 (40.0%) | 3/3 (100.0%) | 6/7 (85.7%) | 3/4 (75.0%) | 24/31 (77.4%) |
ERM | 7 (50.0%) | 6 (60.0% | 8 (80.0%) | 5 (62.5%) | 1 (25.0%) | 27 (58.7%) |
Macular edema | 3 (21.4%) | 4 (40.0%) | 8 (80.0%) | 2 (25.0%) | 0 (0%) | 17 (37.0%) |
ELM disruption | 10 (71.4%) | 6 (60.0%) | 6 (60.0%) | 4 (50.0%) | 3 (75.0%) | 29 (63.0%) |
EZ disruption | 10 (71.4%) | 9 (90.0%) | 8 (80.0%) | 5 (62.5%) | 3 (75.0%) | 35 (76.1%) |
N, ETDRS quadrants | 1.4 ± 0.6 | 4.0 ± 2.6 | 3.3 ± 2.5 | 3.6 ± 1.7 | 1.3 ± 0.5 | 2.7 ± 2.1 |